← Leaderboards
Stacey L Berg
Baylor College Of Medicine
$977,573
Attributed
$977,573
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $97.6K · FY2005–24$100K$75K$50K$25K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$977,573 · 9
By mechanism
P30$955,863 · 5
M01$21,710 · 4
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Martha P Mims$5,499,276
- C Kent Osborne$24,386,086
- David G. Poplack$17,817,283
- Sharmila Anandasabapathy$9,395,698
- Helen E Heslop$25,308,937
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMonitorCollegeMedicineMemberProtocols DocumentationCancer CenterInstitutionWorking GroupHospitalsGene TherapyUnited States National Institutes Of HealthDescriptorReview CommitteeClinical ResearchSafetyProgramsFundingResearch PersonnelExpedited ReviewAuthorityClinicFunding MechanismsInstitutional Review Boards
Grant awards (25)
Protocol Review and Monitoring System$46,561
P30 · FY2024 · CA · contact PI
Protocol Review and Monitoring System$46,561
P30 · FY2023 · CA · contact PI
Protocol Review and Monitoring System$46,561
P30 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$53,159
P30 · FY2021 · CA · contact PI
Protocol Review and Monitoring System$46,561
P30 · FY2020 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-016)$88,388
P30 · FY2019 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-016)$82,836
P30 · FY2018 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-016)$10,000
P30 · FY2018 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-016)$4,755
P30 · FY2018 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-016)$62,481
P30 · FY2017 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-016)$62,481
P30 · FY2016 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM (Core-016)$77,966
P30 · FY2015 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEMS$41,848
P30 · FY2014 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEMS$92,058
P30 · FY2013 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEMS$45,119
P30 · FY2012 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEMS$46,240
P30 · FY2011 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEMS$51,049
P30 · FY2010 · CA · contact PI
ABTR06C1 PHARMACOKINETICS OF DAUNOMYCIN IN CHILDREN$2,670
M01 · FY2010 · RR · contact PI
Protocol Review & Monitoring System$18,787
P30 · FY2009 · CA · contact PI
Protocol Review & Monitoring System$16,332
P30 · FY2008 · CA · contact PI
Protocol Review & Monitoring System$16,120
P30 · FY2007 · CA · contact PI
IMPACT OF BODY COMPOSITION ON PHARMACOKINETICS OF DOXORUBICIN$2,482
M01 · FY2006 · RR · contact PI
IMPACT OF BODY COMPOSITION ON PHARMACOKINETICS OF DOXORUBICIN$5,909
M01 · FY2005 · RR
Impact of Body Composition on Pharmacokinetics of Doxorubicin$8,519
M01 · FY2004 · RR
Phase I Trial of Thalidomide and Carboplatin in Children$2,130
M01 · FY2004 · RR